Abstract
Three new 22-membered macrolactone antibiotics, atacamycins A-C, were produced by Streptomyces sp. C38, a strain isolated from a hyper-arid soil collected from the Atacama Desert in the north of Chile. The metabolites were discovered in our HPLC-diode array screening and isolated from the mycelium by extraction and chromatographic purification steps. The structures were determined by mass spectrometry and NMR experiments. Atacamycins A, B and C exhibited moderate inhibitory activities against the enzyme phosphodiesterase (PDE-4B2), whereas atacamycin A showed a moderate antiproliferative activity against adeno carcinoma and breast carcinoma cells.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / isolation & purification
-
Antineoplastic Agents / pharmacology
-
Cell Line, Tumor
-
Chile
-
Cyclic Nucleotide Phosphodiesterases, Type 4 / metabolism
-
Desert Climate
-
Drug Screening Assays, Antitumor
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / isolation & purification
-
Enzyme Inhibitors / pharmacology
-
Humans
-
Microbial Sensitivity Tests
-
Molecular Structure
-
Mycelium / chemistry
-
Nuclear Magnetic Resonance, Biomolecular
-
Polyketides / chemistry
-
Polyketides / isolation & purification*
-
Polyketides / metabolism*
-
Polyketides / pharmacology
-
Soil Microbiology
-
Spectrometry, Mass, Electrospray Ionization
-
Spectroscopy, Fourier Transform Infrared
-
Streptomyces / chemistry
-
Streptomyces / metabolism*
Substances
-
Antineoplastic Agents
-
Enzyme Inhibitors
-
Polyketides
-
Cyclic Nucleotide Phosphodiesterases, Type 4
-
PDE4B protein, human